Skip to content

Effects of Erbium Laser on Facial Rejuvenation

Effect of Er:YAG laser on labial and buccal mucosa

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9bqqpc8
Enrollment
Unknown
Registered
2025-12-05
Start date
2019-09-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Aging

Interventions

This study will be a randomized, double-blind, controlled clinical trial. Patients will be randomized into four groups: Group 1 - control - will not receive treatment - 20 patients. These patients wil

Sponsors

Faculdade de Odontologia da Universidade de São Paulo (Fousp)
Lead Sponsor
Faculdade de Odontologia da Universidade de São Paulo (Fousp)
Collaborator

Eligibility

Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: Males and females aged 35 to 70 years; in good general health; willing to adhere to the study protocol; presenting a chief complaint of aesthetic dissatisfaction with their lips; and pronounced nasolabial folds

Exclusion criteria

Exclusion criteria: Previous application of fillers or botulinum toxin in the region at any given moment; the possibility and/or presence of pregnancy; active oncologic treatment; and other conditions that lead to alterations in circulatory and or metabolic systems

Design outcomes

Primary

MeasureTime frame
Expected outcome 1: Reduction or increase (in millimeters) of facial lines in the perioral region, assessed at four time points (before, immediately after, 1 month, and 3 months post-intervention).;Finding outcome 1: There were statistically significant improvements in the laser-treated group (Friedman test), demonstrating the treatment effect over time (T0 vs. T1, T2, T3).

Secondary

MeasureTime frame
No secondary outcomes are expected

Countries

Brazil

Contacts

Public ContactPaula Carvalho

Faculdade de Odontologia da Universidade de São Paulo (Fousp)

paulamcarvalho@usp.br+55 91 99313-5595

Outcome results

None listed

Source: REBEC (via WHO ICTRP)